MeSH term
Frequency | Condition_Probility | Animals | 21 | 0.0 |
Humans | 41 | 0.0 |
Mice | 6 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 14 | 0.0 |
Biotransformation | 2 | 0.0 |
Cytochrome P-450 Enzyme System/*metabolism | 4 | 0.0 |
Isoenzymes/metabolism | 4 | 0.0 |
Oxidation-Reduction | 4 | 0.0 |
Recombinant Proteins/metabolism | 5 | 0.0 |
Spectrophotometry, Ultraviolet | 5 | 2.0 |
Substrate Specificity | 8 | 0.0 |
Adolescent | 3 | 0.0 |
Adult | 8 | 0.0 |
Female | 8 | 0.0 |
*Gene Expression Regulation, Developmental | 2 | 0.0 |
Male | 10 | 0.0 |
Microsomes, Liver/enzymology | 7 | 3.0 |
Oxygenases/genetics/*metabolism | 6 | 66.0 |
Cytochrome P-450 Enzyme System/metabolism | 2 | 0.0 |
Amino Acid Sequence | 8 | 0.0 |
Base Sequence | 11 | 0.0 |
Comparative Study | 6 | 0.0 |
DNA, Complementary/isolation & purification | 2 | 1.0 |
Molecular Sequence Data | 13 | 0.0 |
Rabbits | 10 | 0.0 |
Rats | 6 | 0.0 |
Research Support, Non-U.S. Gov't | 18 | 0.0 |
Swine | 6 | 0.0 |
Stereoisomerism | 5 | 1.0 |
Cells, Cultured | 2 | 0.0 |
RNA, Messenger/metabolism | 2 | 0.0 |
Chromatography, High Pressure Liquid | 6 | 0.0 |
Enzyme Inhibitors/pharmacology | 4 | 0.0 |
Kinetics | 5 | 0.0 |
Oxygenases/antagonists & inhibitors/*metabolism | 2 | 33.0 |
In Vitro | 8 | 0.0 |
Microsomes, Liver/metabolism | 2 | 1.0 |
Aged | 3 | 0.0 |
Blotting, Western | 2 | 0.0 |
Liver/embryology/*enzymology | 2 | 18.0 |
Middle Aged | 5 | 0.0 |
Oxygenases/*metabolism | 5 | 20.0 |
Hydrogen-Ion Concentration | 2 | 0.0 |
Time Factors | 2 | 0.0 |
Enzyme Activation/drug effects | 2 | 0.0 |
Structure-Activity Relationship | 5 | 0.0 |
Kidney/enzymology | 2 | 1.0 |
Liver/embryology/enzymology | 2 | 11.0 |
Amines/pharmacology | 2 | 14.0 |
Methimazole/metabolism | 4 | 66.0 |
Catalytic Domain | 2 | 0.0 |
DNA Primers | 2 | 0.0 |
Exons | 2 | 0.0 |
Oxygenases/*genetics/metabolism | 4 | 36.0 |
Transcription, Genetic | 3 | 0.0 |
Variation (Genetics) | 2 | 0.0 |
Sex Characteristics | 2 | 0.0 |
Species Specificity | 2 | 0.0 |
Cloning, Molecular | 8 | 0.0 |
Oxygenases/*genetics | 6 | 25.0 |
Sequence Homology, Amino Acid | 4 | 0.0 |
Oxygenases/*chemistry | 2 | 100.0 |
Guinea Pigs | 2 | 0.0 |
RNA/biosynthesis | 2 | 2.0 |
DNA, Complementary | 3 | 0.0 |
*Promoter Regions (Genetics) | 2 | 0.0 |
Restriction Mapping | 2 | 0.0 |
Sequence Alignment | 2 | 0.0 |
Chromosome Mapping | 3 | 0.0 |
*Chromosomes, Human, Pair 1 | 2 | 0.0 |
Hybrid Cells | 2 | 0.0 |
Liver/enzymology | 3 | 0.0 |
*Multigene Family | 2 | 0.0 |
Polymerase Chain Reaction | 4 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
In Situ Hybridization | 2 | 0.0 |
Microsomes, Liver/drug effects/enzymology | 2 | 2.0 |
DNA/genetics | 3 | 0.0 |
Chromosomes, Human, Pair 1 | 2 | 0.0 |
